Antitumor Responses in the Absence of Toxicity in Solid Tumors by Targeting B7-H3 via Chimeric Antigen Receptor T Cells-Reference-Cited by-同舟云学术

Antitumor Responses in the Absence of Toxicity in Solid Tumors by Targeting B7-H3 via Chimeric Antigen Receptor T Cells

Published:2019-02 Issue:2 Volume:35 Page:221-237.e8
ISSN:1535-6108
Container-title:Cancer Cell
language:en
Short-container-title:Cancer Cell

Author:

Du Hongwei,Hirabayashi Koichi,Ahn Sarah,Kren Nancy Porterfield,Montgomery Stephanie Ann,Wang Xinhui,Tiruthani Karthik,Mirlekar Bhalchandra,Michaud Daniel,Greene Kevin,Herrera Silvia Gabriela,Xu Yang,Sun Chuang,Chen Yuhui,Ma Xingcong,Ferrone Cristina Rosa,Pylayeva-Gupta Yuliya,Yeh Jen Jen,Liu Rihe,Savoldo Barbara,Ferrone Soldano,Dotti Gianpietro

Funder

University of North Carolina

National Cancer Institute

Rivkin Center for Ovarian Cancer

Department of Defense

National Institute of Dental & Craniofacial Reseacrh

Publisher

Elsevier BV

Subject

Cancer Research,Cell Biology,Oncology

Reference60 articles.

1. HER2-specific chimeric antigen receptor-modified virus-specific T cells for progressive glioblastoma: a phase 1 dose-escalation trial;Ahmed;JAMA Oncol.,2017